Noticeably, CD8+TM and NKT lymphopenia was not identified in COVID(−) patients, suggesting that a reduced abundance of CD8+TM and NKTs are specific predictive biomarkers for COVID-19. The gene discussed is CD8A; the disease is lymphopenia.